Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

48.80
Delayed Data
As of Feb 12
 +0.18 / +0.37%
Today’s Change
42.68
Today|||52-Week Range
60.34
-15.98%
Year-to-Date

Today’s Trading

Previous close48.62
Today’s open48.85
Day’s range48.04 - 48.91
Volume1,403,708
Average volume (3 months)1,526,759
Market cap$97.9B
Dividend yield1.56%
Data as of 4:02pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.46%
Revenue growth (last year)+1.43%
P/E ratio3.8
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.61+1.56%
BMYBristol-Myers Squibb+0.68+1.14%
SNYSanofi+0.61+1.59%
ABBVAbbVie+0.40+0.77%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateApril 29, 2016
EPS forecast (this quarter)$0.49
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Partner Offers